Australia's most trusted
source of pharma news
Saturday, 02 August 2025
Posted 29 July 2025 PM
Brandon Capital has raised $439 million for Brandon BioCatalyst Fund Six, almost $100 million more than it envisioned, with government joining in.
The fund launched a little over a year ago with hopes of raising up to $350 million to invest in emerging biomedical technologies with strong commercial potential, with the aim of translating the discoveries into high-growth firms that positively impact human health.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.